Toxicological effect of engineered nanomaterials on the liver

British Journal of Pharmacology

Volumn 171, Issue 17, 2014, Pages 3980-3987

  Kermanizadeh, A ^a   Gaiser, B K ^a   Johnston, H ^a   Brown, D M ^a   Stone, V ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

inflammation; liver; nanomaterials; oxidative stress; toxicity

Indexed keywords

CELL DNA; MULTI WALLED NANOTUBE; NANOMATERIAL; TITANIUM DIOXIDE; ZINC OXIDE;

APOPTOSIS; BIOACCUMULATION; COMPARATIVE STUDY; CYTOTOXICITY; DETOXIFICATION; DISEASE COURSE; DNA FRAGMENTATION; HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LC 50; LIVER CELL; LIVER FUNCTION; LIVER METABOLISM; LIVER TOXICITY; METABOLIC REGULATION; NANOENGINEERING; NANOTOXICOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; ANIMAL; DRUG EFFECTS; LIVER; METABOLISM;

ANIMALS; HUMANS; LIVER; NANOSTRUCTURES;

EID: 84906065831     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12421     Document Type: Review

References (45)

1. Baffy G, (2009). Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 51: 212-223.
2. Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY, (2010). Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 13: 2034-2042.
3. 3+ containing (hematite) particles for their toxicological properties in human lung cells in vitro. Toxicol Sci 126: 173-182.
4. Buzea C, Pacheco II, Robbie K, (2007). Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2: 18-67.
5. Chen C, Zhang P, Hou X, Chai Z, (1999). Sub-cellular distribution of selenium and Se-containing proteins in human liver. Biochim Biophys Acta 1427: 205-215.
6. Cho WS, Kim S, Han BS, Son WC, Jeong J, (2009). Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100-nm sized PEG coated gold nanoparticles. Toxicol Lett 191: 96-102.
7. Diesen DL, Kuo PC, (2009). Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. J Surg Res 162: 95-109.
8. Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, et-al. (1998). Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. Am J Roentgenol 171: 449-454.
9. Downs TR, Crosby ME, Hu T, Kumar S, Sullivan A, Sarlo K, et-al. (2012). Silica nanoparticles administrated at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. Mutat Res 745: 38-50.
10. Dragoni S, Franco G, Regoli M, Bracciali M, Morandi V, Sgaragli G, et-al. (2012). Gold nanoparticles uptake and cytotoxicity assessed on rat liver precision cut slices. Toxicol Sci 128: 186-197.
11. Elbakry A, Wurster EC, Zaky A, Liebl R, Schindler E, Baur-Kreisel P, et-al. (2012). Layer-by-layer coated gold nanoparticles: size-dependant delivery of DNA into cells. Small 8: 3847-3856.
12. Fadeel B, (2012). Clear and present danger? Engineered nanoparticles and the immune response. Swiss Med Wkly 142: w13609. doi: 10.4414/smw.2012.13609.
13. Fainboim L, Chernavsky A, Paladino N, Flores AC, Arruvito L, (2007). Cytokines and chronic liver disease. Cytokine Growth Factor Rev 18: 143-157.
14. Gaiser BK, Fernandes TF, Jepson MA, Lead JR, Tyler CR, Baalousha M, et-al. (2011). Interspecies comparisons on the uptake and toxicity of silver and cerium dioxide nanoparticles. Environ Toxicol Chem 31: 144-154.
15. Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, et-al. (2013). Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 131: 537-547.
16. Hoet PHM, Hohlfeld IB, Salata O, (2004). Nanoparticles-known and unknown health risks. J Nanobiotechnology 2: 12-27.
17. Jackson P, Hougaard KS, Vogel U, Wu D, Casavant L, Williams A, et-al. (2012). Exposure of pregnant mice to carbon black by intratracheal instillation: toxicogenomic effects in dams and offspring. Mutat Res 745: 73-83.
18. Jin CY, Zhu BS, Wang XF, Lu QH, (2008). Cytotoxicity of Titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol 21: 1871-1877.
19. Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V, (2012). Investigating the relationship between nanomaterial hazard and physicochemical properties: informing the exploitation of nanomaterials with therapeutic and diagnosis applications. J Control Release 164: 307-313.
20. Kang KJ, (2002). Mechanism of hepatic ischemia/reperfusion injury and protection against reperfusion injury. Transplant Proc 34: 2659-2661.
21. Kermanizadeh A, Gaiser BK, Hutchison GR, Stone V, (2012). An in vitro liver model-assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanoparticles. Part Fibre Toxicol 9: 28. doi: 10.1186/1743-8977-9-28.
22. Kermanizadeh A, Brown DM, Hutchison G, Stone V, (2013a). Engineered nanomaterial impact in the liver following exposure via an intravenous route-the role of polymorphonuclear leukocytes and gene expression in the organ. Nanomedicine Nanotechnol 4: 157. doi: 10.4172/2157-7439.1000157.
23. Kermanizadeh A, Gaiser BK, Ward MB, Stone V, (2013b). Primary human hepatocytes vs. hepatic cell line-assessing their suitability for in vitro nanotoxicology. Nanotoxicology 7: 1255-1271. doi: 10.3109/17435390.2012.734341.
24. Kermanizadeh A, Pojana G, Gaiser BK, Birkedal R, Bilaničová D, Wallin H, et-al. (2013c). In vitro assessment of engineered nanomaterials using C3A cells: Cytotoxicity, pro-inflammatory cytokines and function markers. Nanotoxicology 7: 301-313. doi: 10.3109/17435390.2011.653416.
25. Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, et-al. (2009). Oxidative stress-dependant toxicity of silver nanoparticles in human hepatoma cells. Toxicol in Vitro 23: 1076-1084.
26. Kmiec Z, (2001). Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 161: 1-151.
27. Lieber CS, (1997). Role of oxidative stress and antioxidant therapy in alcoholic and non alcoholic liver diseases. Adv Pharmacol 38: 601-628.
28. Lin HJ, Bu Q, Cen XB, Zhao YL, (2012). Current methods and research progress in nanomaterials risk assessment. Curr Drug Metab 13: 354-363.
29. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, et-al. (2006). Safe handling of nanotechnology. Nature 444: 267-269.
30. Nalabotu SK, Kolli MB, Triest WE, Ma JY, Manne NDPK, Katta A, et-al. (2012). Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats. Int J Nanomedicine 6: 2327-2335.
31. Oberdorster G, Maynard A, Donaldson K, Castronova V, Fitzpatrick J, Ausman K, et-al. (2005). Principles for characterising the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2: 8. doi: 10.1186/1743-8977-2-8.
32. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, et-al. (2011). Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201: 92-100.
33. Project on Emerging Nanotechnologies (2013). Consumer products inventory. Available at: http://www.nanotechproject.org/cpi (accessed 10/2/2013).
34. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, et-al. (2007). Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4: 10. doi: 10.1186/1743-8977-4-10.
35. Sadauskas E, Jacobsen NR, Danscher G, Stoltenberg M, Vogel U, Larsen A, et-al. (2009). Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J 3: 16. doi: 10.1186/1752-153X-3-16.
36. Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, et-al. (2008). Biodistribution of 1.4- and 18-nm gold particles in rats. Small 12: 2108-2111.
37. Sha BY, Gao W, Wang SQ, Feng X, Lu T, (2011). Cytotoxicity of titanium dioxide nanoparticles in four liver cells from human and rat. Composites 42: 2136-2144.
38. Sharma V, Singh P, Pandey AK, Dhawan A, (2012). Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute exposure to zinc oxide nanoparticles. Mutat Res 745: 84-91.
39. 2 nanoparticles induce oxidative DNA damage and apoptosis in human liver cells. Nanotoxicology 7: 48-60.
40. Stadnyk AW, Baumann H, Gauldie J, (1990). The acute-phase protein response in parasite infection. Nippostrongylus brasiliensis and Trachinella spiralis in the rat. Immunology 69: 588-595.
41. Stern ST, Adiseshaiah PP, Crist RM, (2012). Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 9: 20. doi: 10.1186/1743-8977-9-20.
42. Teodoro JS, Simoes AM, Duarte FV, Rolo AP, Murdoch RC, Hussain SM, et-al. (2011). Assessment of toxicity of silver nanoparticles in vitro: a mitochondrial perspective. Toxicol in Vitro 2: 664-670.
43. Thomas KV, Farkas J, Farman E, Christian P, Langford K, Wu Q, et-al. (2011). Effects of dispersed aggregates of carbon and titanium dioxide engineered nanoparticles on rainbow trout hepatocytes. J Toxicol Environ Health 74: 466-477.
44. Tiegs G, Lohse AW, (2009). Immune tolerance: what is unique about the liver. J Autoimmun 34: 1-6.
45. Yuan J, Gao H, Sui J, Duan H, Chen WN, Ching CB, (2012). Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and grapheme oxide on human hepatoma HepG2 cells: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. Toxicol Sci 12: 149-161.